» Authors » Camilla Lisanti

Camilla Lisanti

Explore the profile of Camilla Lisanti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 235
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazzega-Fabbro C, Polesel J, Brusutti L, Malnis E, Sirelli C, Drigo A, et al.
Cancers (Basel) . 2023 Nov; 15(21). PMID: 37958348
Background: In addition to pharmacological prevention, chemotherapy-induced nausea and vomiting (CINV) can be mitigated through patient education; written supporting materials can be beneficial. Methods: This is a randomized, controlled trial...
2.
Brisotto G, Montico M, Turetta M, Zanussi S, Cozzi M, Vettori R, et al.
Viruses . 2023 Jun; 15(6). PMID: 37376576
Cellular and humoral immunity are both required for SARS-CoV-2 infection recovery and vaccine efficacy. The factors affecting mRNA vaccination-induced immune responses, in healthy and fragile subjects, are still under investigation....
3.
Lisanti C, Basile D, Garattini S, Parnofiello A, Corvaja C, Cortiula F, et al.
Cancers (Basel) . 2023 Jan; 15(1). PMID: 36612170
Background: Emerging data suggest that gender-related immune system composition affects both immune response and efficacy of immunotherapy in cancer patients (pts). This study aimed to investigate the sex-related prognostic role...
4.
Di Nardo P, Lisanti C, Garutti M, Buriolla S, Alberti M, Mazzeo R, et al.
Expert Opin Drug Saf . 2022 Dec; 21(11):1341-1355. PMID: 36469577
Introduction: Neo/adjuvant therapy for early-stage breast cancer has become increasingly common in the last few decades; as a consequence, the number of breast cancer survivors experiencing often debilitating long-term side...
5.
Risi E, Lisanti C, Vignoli A, Biagioni C, Paderi A, Cappadona S, et al.
Transl Oncol . 2022 Nov; 27:101585. PMID: 36403505
Background: We previously showed that metabolomics predicts relapse in early breast cancer (eBC) patients, unselected by age. This study aims to identify a "metabolic signature" that differentiates eBC from advanced...
6.
Garattini S, Basile D, Bonotto M, Ongaro E, Porcu L, Corvaja C, et al.
Cancers (Basel) . 2021 Jul; 13(14). PMID: 34298718
Different de-escalation strategies have been proposed to limit the risk of cumulative toxicity and guarantee quality of life during the treatment trajectory of patients with metastatic colorectal cancer (mCRC). Programmed...
7.
Pelizzari G, Cortiula F, Giavarra M, Bartoletti M, Lisanti C, Buoro V, et al.
Drugs Aging . 2020 Jul; 37(9):677-689. PMID: 32681401
Background: The role of platinum-based chemotherapy (PBC) for the treatment of older patients with non-small cell lung cancer (NSCLC) is still a matter of debate, despite the advent of immunotherapy....
8.
Bonotto M, Basile D, Gerratana L, Bartoletti M, Lisanti C, Pelizzari G, et al.
Future Oncol . 2020 Jun; 16(27):2059-2073. PMID: 32598185
A monitoring strategy for metastatic breast cancer patients (M-MBC) has been little studied. This retrospective study analyzed a consecutive cohort of 382 MBC patients to analyze different M-MBC strategies to...
9.
Lisanti C, Basile D, Parnofiello A, Bertoli E, Andreotti V, Garattini S, et al.
J Geriatr Oncol . 2020 Jun; 11(8):1268-1273. PMID: 32576519
Background: Aging induces meaningful changes in the immune system and inflammation response with increase in monocyte-lymphocyte ratio (MLR) and serum lactate dehydrogenase (LDH) levels. Aim of this study was to...
10.
Basile D, Bartoletti M, Polano M, Bortot L, Gerratana L, Di Nardo P, et al.
Clin Nutr . 2020 Jun; 40(1):286-294. PMID: 32546390
Background: Body composition, has been established as a risk factor for colorectal cancer diagnosis and disease progression. Aim of this study was to investigate the prognostic role of adiposity, especially...